Advertisement
NeuroScientistNews
NeuroScientistNews

The Scientist

» public health

Most Recent

image: Next Generation: Painless Vaccine Patch

Next Generation: Painless Vaccine Patch

By | April 2, 2012

Vaccination via tiny microneedles elicits a powerful immune response in the skin.

8 Comments

image: Obesity Drugs in Check

Obesity Drugs in Check

By | April 2, 2012

The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.

2 Comments

image: Bushmeat Roulette

Bushmeat Roulette

By | April 1, 2012

Pathogens lurk in illegal wildlife products confiscated at US airports.

12 Comments

image: My DNA, My Results

My DNA, My Results

By | March 22, 2012

Are donors of biological material privy to research results that stem from their donation?

2 Comments

image: Opinion: A Truly Public Lab?

Opinion: A Truly Public Lab?

By | March 21, 2012

Should the healthcare system support health and wellness data tracking for the purposes of long-term observational studies?

22 Comments

image: Trouble at the CDC?

Trouble at the CDC?

By | March 12, 2012

Anonymous letters to The Lancet point to problems with the CDC's Center for Global Health, but the agency denies the allegations.

4 Comments

image: High Tumor Heterogeneity Confirmed

High Tumor Heterogeneity Confirmed

By | March 9, 2012

One biopsy may not provide enough information about the array of mutations in cancer to devise treatments based on a tumor’s genetic profile.

2 Comments

image: H5N1 Insiders Speak Out

H5N1 Insiders Speak Out

By | March 6, 2012

NSABB and Congress members voice their opinions about the new developments in the H5N1 research debate.

0 Comments

image: Are the Kids Alright?

Are the Kids Alright?

By | March 1, 2012

Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?

6 Comments

image: How the Pediatric Laws Work

How the Pediatric Laws Work

By | March 1, 2012

The Pediatric Research Equity Act (PREA) of 2003 requires that companies developing new drugs that could be used to treat a condition in children perform clinical trials in kids before winning FDA approval. 

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies